BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 598007)

  • 1. Modified paper chromatographic method for assay of myocardial depressant factor.
    Yamada T; Pettit GW
    Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality.
    Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L
    J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on a pancreatic cardiodepressant factor.
    Sagher U; Rosen H; Sarel O; Becker Y
    Circ Shock; 1986; 19(3):319-27. PubMed ID: 3731406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial depressant factor in shock].
    Okada K; Kosugi I; Yamaguchi Y; Innami H; Kawashima Y
    Masui; 1973 May; 22(5):414-22. PubMed ID: 4737987
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
    Coraim FI; Laufer G; Ilias W; Wollenek G; Wolner E
    Prog Clin Biol Res; 1987; 236A():611-20. PubMed ID: 2441410
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the myocardial depressant factor in the pathogenesis of the shock].
    Pagni E
    Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comments: controversy over myocardial depressant factor in shock.
    Lefer AM; Glenn TM
    J Trauma; 1973 Aug; 13(8):746-51. PubMed ID: 4720998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Positive modification of hemodynamics in post cardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor (MDF) in hemofiltrate].
    Coraim F; Pauser G; Stellwag F; Werner T; Ziegler W
    Anaesthesist; 1985 May; 34(5):236-40. PubMed ID: 4025793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of shock-induced circulating cardiodepressant substances: a brief review.
    Goldfarb RD
    Circ Shock Suppl; 1979; 1():23-33. PubMed ID: 111872
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

  • 13. MDF: its participation in the pathophysiology of shock.
    Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
    Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed appearance of a circulating myocardial depressant factor in burn patients.
    De Santis D; Phillips P; Spath MA; Lefer AM
    Ann Emerg Med; 1981 Jan; 10(1):22-4. PubMed ID: 7458026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 17. [Humoral factors in cardiogenic shock].
    Kölbel F; Veselý P
    Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
    [No Abstract]   [Full Text] [Related]  

  • 18. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on low molecular weight inotropic plasma substances in prolonged hypovolemic traumatic shock.
    Hallström S; Vogl C; Krösl P; Redl H; Schlag G
    Prog Clin Biol Res; 1987; 236A():591-7. PubMed ID: 3615453
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.